控制医药费用是落实国家“总量控制,结构调整”的政策方针的重要举措。为了降低医疗费用,医院管理部门一般对临床科室采用限制科室药品比例的方法来限制药品的过高增长[1],如何在不违背国家药品价格和临床应用政策的前提下,依据实际情况进行药品采购预算编制,是一个较为棘手的问题。本文从药品管理的角度切入,提出优化药品结构的一些 Controlling medical expenses is an important measure for implementing the policy of “total amount control and structural adjustment” of the state. In order to reduce medical expenses, hospital departments generally limit the proportion of medicines in clinical departments to limit the excessive growth of medicines [1]. How to carry out medicines according to the actual conditions without violating the national drug prices and clinical application policies? Procurement budget preparation, is a more difficult issue. This article from the pharmaceutical management point of view, put forward to optimize some of the drug structure